Products
Community
Markets
News
Brokers
More

Markets
Stocks
NBIX

Neurocrine

No trades

See on Supercharts

Overview

News Ideas Discussions Seasonals

NBIX chart

Full chart

Key facts today

Barclays has maintained an Overweight rating for Neurocrine Biosciences, Inc. (NBIX) and increased its price target to $165.00 per share, up from a previous target of $160.00.

Analyze the impact Analyze the impact

NBIX news

Keep reading

Ideas

Neurocrine Stock Quote | Chart & Forecast Summary Key Indicators On Trade Set Up In General 1. Push Set Up 2. Range Set up 3. Break & Retest Set Up Notes On Session # Neurocrine Stock Quote - Double Formation * Retracement | Not Numbered | A+ Set Up Area | Subdivision 1 * Wedge Structure | 117.00 USD & 106.00 USD | Subdivision 2 - Triple Formatio

Long

by TradePolitics

NBIX -Long -TP>25%NASDAQ:NBIX - LONG - RISK 1/5 - TP > 25% We already have a buy position. Good luck to everyone... ==============================

Long

by stsidx

NBIX -Long -TP>25%NASDAQ:NBIX -Long -TP>25-30% and more -waiting for a point to enter a long position

Long

by stsidx

Solid Growth but Misses Q2 Earnings Targets Neurocrine Biosciences Inc. (NASDAQ: NBIX) is continuing to advance its position in the biotech sector, despite facing a slight setback in its Q2 2024 earnings report. The company posted revenue of $590.2 million, which was higher than analyst estimates of $545.9 million, representing a 30.4% year-o

Long

by olimchik

Textbook bullish flag It looks like a beautiful flag (or pennant) to me, with high volume at the pole and the volume drying up during the consolidation. I am expecting continuation.

Long

by dobisa

Updated

(Potential Trade) NBIX (13 May 2024) Disclaimer: All information posted are the author's own trades/potential trades. The author is not a certified Financial Advisor and do not have the certifications to provide financial advice. These information are strictly for educational purposes only and do not constitute any finan

Long

by ElliotWaveTrades

Updated

NBIX Biotechnology / Pharmaceutical Pre-earnings LONG Neurocrine Biosciences, a mid cap pharmaceutical firm is up for earnings on February 7th. Investor and trader interest seems to be moderately increasing in the past week. The combined MACD / RSI indicator is bullish. This looks good for a longtrade to be taken in the premarket before 7:45 AM

Long

by AwesomeAvani

Updated

"NBIX Stock Breaks All-Time Highs, Strong Buy Opportunity!"NBIX Stock Breaks All-Time Highs: A Strong Buy Opportunity Emerges Neurocrine Biosciences Inc. (NBIX) is currently making waves in the stock market as it breaks out of its all-time highs, signaling a promising opportunity for investors. After 14 years of steady upward momentum and price consolidat

Long

by UnknownUnicorn2319099

Neurocrine Biosciences (NBIX: NASDAQ)Neurocrine Biosciences (NBIX), a biotech company specializing in treatments for neurological, endocrine, and psychiatric disorders, is poised for opportunities in congenital adrenal hyperplasia (CAH). Analysts project NBIX to potentially achieve worldwide revenue of $660 million by fiscal year 2030,

Long

by Richtv_official

NBIX view(personal)For this stock i have done some deep analysis including looking at the financial reports and estimated points provided by big bank analyst. i have come to the conclusion that after this close below the strong daily support. this pair is likely going to go to the 95 dollar zone within 2 weeks and fr

Long

by PHANTOMFX_

Updated

See all ideas

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.

Sparks

Curated watchlists where NBIX is featured.

Biotech stocks: A shot in the arm

See all sparks

Love in every #TradingView

90M+

Traders and investors use our platform.

Top website in the world when it comes to all things investing.

1.5M+

Mobile reviews with 4.9 average rating. No other fintech apps are more loved.

10M+

Custom scripts and ideas shared by our users.

@andyoh6666

@garret_duke

@bradfairbridge

@tradingfrance

@mariodelpo

@trader_bence01

@Arcanebear.eth

@arcanebear

@cenobar

@ftmocom

@__paid__with__kevin__

@akilstokesrtm

@neo_inversion

@mytradingsetup

@sophie.burrell__

@mavrricck

@sinasfx

@falcon_invest1

Whatever the trade

Here's why Here's why

Products

Supercharts
Pine Script™
Stock Screener
ETF Screener
Bond Screener
Forex Screener
Crypto Coins Screener
Crypto Pairs Screener
DEX Pairs Screener
Stock Heatmap
ETF Heatmap
Crypto Heatmap
Economic Calendar
Earnings Calendar
Sparks
News
TradingView Desktop
Mobile app
CME Group futures
Eurex futures
US stocks bundle

Company

About
Features
Pricing
Social network
Wall of Love
Athletes
Manifesto
Careers
Blog
Security vulnerability
Status page
Terms of use
Disclaimer
Privacy policy
Cookies policy
Media kit
Accessibility statement
Tarot cards for traders

Community

Refer a friend
Ideas
Scripts
House rules
Moderators
Pine Script™ Wizards
Chat
Your festive recap

For business

Widgets
Advertising
Charting libraries
Lightweight Charts™
Advanced Charts
Trading Platform
Brokerage integration
Partner program
Education program

Neurocrine

NBIX chart﻿

Key facts today

NBIX news﻿

Ideas﻿

Seasonals﻿

Sparks﻿

NBIX chart

NBIX news

Ideas

Seasonals

Sparks